Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasburicase vs Allopurinol for Hyperuricemia in ALL/NHL
NCT00199043Phase 3Completed
- Sponsor
- Goethe University Frankfurt
- Start
- May 2003
- Primary completion
- May 2008
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rasburicase in hyperuricemia, tumor lysis syndrome (TLS), sponsored by Goethe University Frankfurt. Started May 2003; status: completed.
02
Drugs
rasburicase
03
Conditions
hyperuricemiatumor lysis syndrome (TLS)
Beyond the preview
Go deeper on NCT00199043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199043.